Wave Life Sciences WVE JP — Deferred Tax Assets Operating Loss Carryforwards

Similar metrics at other companies

LACCA — Deferred Tax Assets Operating Loss Carryforwards

$16.2M+1.9%

LACUS — Deferred Tax Assets Operating Loss Carryforwards

$288.5M+12.0%

LSAKUS — Deferred Tax Assets Operating Loss Carryforwards

$30.8M—

LSAKZA — Deferred Tax Assets Operating Loss Carryforwards

$212.1M—

VSATGB — Deferred Tax Assets Operating Loss Carryforwards

$64.2M—

VHI

VHIUS — Deferred Tax Assets Operating Loss Carryforwards

$12.2M—

FAQ

What is Wave Life Sciences's JP — deferred tax assets operating loss carryforwards?

Wave Life Sciences (WVE) reported JP — deferred tax assets operating loss carryforwards of $100K in Q4 2025.

How has Wave Life Sciences's JP — deferred tax assets operating loss carryforwards changed year-over-year?

Wave Life Sciences's JP — deferred tax assets operating loss carryforwards decreased by 85.7% year-over-year, from $700K to $100K.

What does JP — deferred tax assets operating loss carryforwards mean?

This metric represents the total value of tax losses generated within the Japan geographic segment that can be carried forward to offset future taxable income. It serves as a potential tax shield, reflecting the historical cumulative losses of the regional operations. Investors monitor this to assess the future tax savings potential and the company's ability to utilize these assets against future profitability in the Japanese market.